Amarin Corporation plc (AMRN) AMR101 approved by the FDA
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Join SI Premium – FREE
Amarin Corporation plc (Nasdaq: AMRN) AMR101 approved by the FDA according to theStreet.com's Adam Feuerstein
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amarin to present REDUCE-IT analyses at ESC Congress 2026
- AbbVie seeks EMA approval for Skyrizi subcutaneous use in Crohn's
- New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
Create E-mail Alert Related Categories
FDA, Hot FDA NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
